Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Could sirolimus turn out to be the elixir of life?

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

The immunosuppressant drug sirolimus (rapamycin) has been found to extend the lifespan of middle-aged mice by around a third, giving rise to hopes that it could also prolong life in humans.

When mice aged 20 months old, equivalent to 60 years of age in humans, were given sirolimus in a study reported in Nature, their life expectancy increased by 28–38 per cent. In human terms, this would be greater than the predicted increase in life expectancy if cancer and heart disease were eradicated.

“We believe this is the first convincing evidence that the ageing process can be slowed and lifespan can be extended by a drug therapy starting at an advanced age,” says Randy Strong, director of the National Institute on Aging Interventions Testing Center.

Research has thus far only identified two life-extending interventions in mammals: calorie restriction and genetic manipulation. The mode of action of sirolimus appears to be a partial shutdown of the same molecular pathway as reducing food intake.

It does so through a cellular protein called mTOR (mammalian target of rapamycin), which controls many metabolic processes and responses to stress.

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

From: Beyond pharmacy blog

Take a look here for thoughts and musings beyond the pharmacy realm

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.